Acro Biomedical (ACBM) Return on Capital Employed Growth (3y) (2020 - 2025)
Acro Biomedical (ACBM) Return on Capital Employed Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.93 Mn | 477.93 Mn | - | - |
| 2 | GP-Act III Acquisition | 312.80 Mn | 312.80 Mn | - | - |
| 3 | Berto Acquisition | 311.56 Mn | 311.56 Mn | - | - |
| 4 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | - |
| 5 | Centurion Acquisition | 310.21 Mn | 310.21 Mn | - | - |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | - |
| 7 | Agriculture & Natural Solutions Acquisition | 303.81 Mn | 303.81 Mn | - | - |
| 8 | Bold Eagle Acquisition | 274.64 Mn | 274.64 Mn | - | - |
| 9 | Live Oak Acquisition Corp. V | 265.88 Mn | 265.88 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | 345,619.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 345,619.00 |
| Sep 30, 2025 | 311,543.00 |
| Jun 30, 2025 | 239,523.00 |
| Mar 31, 2025 | 170,616.00 |
| Dec 31, 2024 | 127,724.00 |
| Sep 30, 2024 | -186,103.00 |
| Jun 30, 2024 | -192,014.00 |
| Mar 31, 2024 | -86,494.00 |
| Sep 30, 2023 | -6.22 Mn |
| Jun 30, 2023 | -378,507.00 |
| Mar 31, 2023 | -372,649.00 |
| Dec 31, 2022 | -336,934.00 |
| Sep 30, 2022 | -303,630.00 |
| Jun 30, 2022 | -236,950.00 |
| Mar 31, 2022 | -170,631.00 |
| Dec 31, 2021 | -130,097.00 |
| Sep 30, 2021 | -69,958.00 |
| Jun 30, 2021 | -18,543.00 |
| Mar 31, 2021 | -5,045.00 |
| Sep 30, 2020 | -1,606.00 |